Singapore-based precision gut microbiome company AMILI has snapped up $10.5 million in a Series A funding round led by technology and life sciences investor Vulcan Capital.
New investors also joined the round, including Pruksa Group, TVM Capital Healthcare, Emtek Group, Capital Code, Pureland Group, Blue7 and Enterprise Singapore's investment arm SEEDS Capital.
WHAT IT DOES
Founded in 2019, the...
Viome Life Sciences announced Wednesday it had raised $54 million in a pre-Series C convertible funding round.
Participants in the round include existing investors Khosla Ventures, West River Group, Glico, Physician Partners and Bold Capital Group alongside new investor Ocgrow Ventures.
Viome said this latest investment brings its total capitalization to $125 million.
WHAT THEY DO
Viome is split...
At-home microbiome testing company Ombre, formerly Thryve, has raised $3 million in seed funding, bringing its total raise to $9.5 million.
The round was led by PivotNorth Capital with participation from Trail Mix Ventures, Shanda Group, Unilever Ventures, Social Starts' fund Joyance Partners and Unpopular Ventures.
In addition to the name change, the company also hired new CEO Elise Contarsy,...
Viome Life Sciences, maker of at-home tests for gut and immune system health, is expanding its partnership with global pharma company GlaxoSmithKline to research and potentially develop interventions for some cancers and autoimmune diseases.
The collaboration will allow the companies to study the connection between the gut microbiome and some chronic diseases, like autoimmune disorders. Viome...
Editor's note: A previous version of this story incorrectly placed the raise at $5.1 million. We apologize for this error.
Digital gastrointestinal health company Vivante Health has pulled in another $5.8 million, largely from Lifeforce Capital and Big Pi Ventures. NFP Ventures, FCA Venture Partners and Longmont Capital also took part in the Series A1 round.
WHAT THEY DO
Vivante’s GIThrive is a...
DayTwo, an Israeli company that analyzes gut microbiomes to assist with nutrition and glycemic control, has raised $31 million in Series B financing. Ofek Ventures and aMoon led the round, with additional support coming from prior backers Seventure Partners and Johnson & Johnson.
With this, the company brings its total backing to $48 million.
WHAT THEY DO
DayTwo’s platform asks patients to...
Personalized wellness company Arivale has shut down its consumer operations, according to a statement posted on the company's website. MedCityNews first spotted the post.
"Regrettably, effective today, we are terminating our consumer program," the team wrote in an unsigned note. "Our decision to do so is attributable to the simple fact that the cost of providing the service exceeds what our...
A group of researchers at RMIT University in Melbourne, Australia have developed a new ingestible sensor for a novel purpose: investigating the microbiome and gasses in the gut. In a new study published in Nature Electronics, researchers display not only the potential of the new ingestible sensor, but new learnings that suggest, among other things, a previously undiscovered defense system in the...
DayTwo, an Israeli startup focused on delivering insights to consumers based on their gut microbiome, has raised $12 million from an impressive suite of investors including Johnson & Johnson Innovation and the Mayo Clinic. Seventure Partners' Health for Life Capital Fund also contributed along with private investors including cofounder Marius Nacht.
The startup, which has raised $17 million...
A new longitudinal study of the microbiome from researchers at Harvard and MIT demonstrates how the ubiquity of a smartphone enables research that would have been much more difficult previously. In the study, two patients tracked a number of health factors on an iPhone app for a year and also took stool samples almost every day. Researchers analyzed the bacteria in the stool samples alongside the...
